BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18715461)

  • 1. Lymphatic obstruction and protein-losing enteropathy in patients with congenital heart disease.
    Meadows J; Gauvreau K; Jenkins K
    Congenit Heart Dis; 2008; 3(4):269-76. PubMed ID: 18715461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment.
    Meadows J; Jenkins K
    Cardiol Young; 2011 Aug; 21(4):363-77. PubMed ID: 21349233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-losing enteropathy and the Fontan operation.
    Johnson JN; Driscoll DJ; O'Leary PW
    Nutr Clin Pract; 2012 Jun; 27(3):375-84. PubMed ID: 22516942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic characteristics before and after the onset of protein losing enteropathy in patients after the Fontan operation.
    Ohuchi H; Yasuda K; Miyazaki A; Kitano M; Sakaguchi H; Yazaki S; Tsuda E; Yamada O
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):e49-57. PubMed ID: 23396878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-losing enteropathy after fontan surgery: is assessment of risk patients with immunological data possible?
    Lenz D; Hambsch J; Schneider P; Tárnok A
    Cytometry B Clin Cytom; 2003 May; 53(1):34-9. PubMed ID: 12717689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Clinical Profiles in Patients with Protein-Losing Enteropathy With and Without Fontan Circulation.
    Ono S; Ohuchi H; Miyazaki A; Yamada O
    Pediatr Cardiol; 2018 Oct; 39(7):1290-1298. PubMed ID: 29789917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases.
    Lin WS; Hwang MS; Chung HT; Chu JJ; Lai MW; Yang JS; Huang SC; Huang JL; Su WJ
    Chang Gung Med J; 2006; 29(5):505-12. PubMed ID: 17214396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low pulmonary vascular compliance predisposes post-Fontan patients to protein-losing enteropathy.
    Yu JJ; Yun TJ; Yun SC; Im YM; Lee SC; Shin HJ; Ko HK; Park JJ; Seo DM; Kim YH; Ko JK; Park IS
    Int J Cardiol; 2013 May; 165(3):454-7. PubMed ID: 21944467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent exacerbations of protein-losing enteropathy after initiation of growth hormone therapy in a Fontan patient controlled with spironolactone.
    Grattan MJ; McCrindle BW
    Congenit Heart Dis; 2010; 5(2):165-7. PubMed ID: 20412490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fontan-associated protein-losing enteropathy and post‒heart transplant outcomes: A multicenter study.
    Schumacher KR; Yu S; Butts R; Castleberry C; Chen S; Edens E; Godown J; Johnson J; Kemna M; Lin K; Lowery R; Simpson K; West S; Wilmot I; Gossett JG
    J Heart Lung Transplant; 2019 Jan; 38(1):17-25. PubMed ID: 30391195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forty years of the Fontan operation: a failed strategy.
    Rychik J
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2010; 13(1):96-100. PubMed ID: 20307870
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies to treat protein-losing enteropathy.
    Rychik J; Spray TL
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2002; 5():3-11. PubMed ID: 11994860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thoracic Duct Decompression for Protein-Losing Enteropathy in Failing Fontan Circulation.
    António M; Gordo A; Pereira C; Pinto F; Fragata I; Fragata J
    Ann Thorac Surg; 2016 Jun; 101(6):2370-3. PubMed ID: 27211948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protein-losing enteropathy following Fontan operation for a complex heart defect].
    Galal O; Kersten J; Götze H; Stoermer J
    Monatsschr Kinderheilkd; 1984 Nov; 132(11):870-2. PubMed ID: 6513949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Early Glenn Operation May be Associated with the Later Occurrence of Protein-Losing Enteropathy in Fontan Patients : Association of Early Glenn and Failing Fontan.
    Unseld B; Stiller B; Borth-Bruhns T; du Bois F; Kroll J; Grohmann J; Fleck T
    Pediatr Cardiol; 2017 Aug; 38(6):1155-1161. PubMed ID: 28534240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Abnormalities in Fontan Protein-Losing Enteropathy: A Case-Control Study.
    Magdo HS; Stillwell TL; Greenhawt MJ; Stringer KA; Yu S; Fifer CG; Russell MW; Schumacher KR
    J Pediatr; 2015 Aug; 167(2):331-7. PubMed ID: 26009017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of heparin in the treatment of protein-losing enteropathy after fontan operation for complex congenital heart disease.
    Kelly AM; Feldt RH; Driscoll DJ; Danielson GK
    Mayo Clin Proc; 1998 Aug; 73(8):777-9. PubMed ID: 9703306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms.
    Ostrow AM; Freeze H; Rychik J
    Ann Thorac Surg; 2006 Aug; 82(2):695-700. PubMed ID: 16863787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-losing enteropathy after Fontan operation.
    Rychik J
    Congenit Heart Dis; 2007; 2(5):288-300. PubMed ID: 18377444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposal for Prevention or Alleviation of Protein/Lymph-Losing Enteropathy (PLE/LLE) After Fontan Circulation Treatment of Univentricular Hearts: Restoration of Lymph Balance With a "Lymphatic Right-to-Left Shunt.".
    James H; Witte MH; Bernas M; Barber B
    Lymphology; 2016 Sep; 49(3):114-27. PubMed ID: 29906066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.